• Citer

Docetaxel in combination with Amifostine (A) in metastatic breast cancer (MBC): A feasability and pharmacokinetic study of the EORTC-investigational drug branch for breast cancer (IDBBC)

par Awada, Ahmad ;Cornez, Nathalie ;de Valeriola, Dominique ;Gil, Thierry ;Van Vreckem, Ann;Bartholomeus, Sylvie;Selleslags, Jean;Piccart-Gebhart, Martine ; [et al.]
Référence (Juin 1997: Lugano, Switzerland), Proceedings of the First International Symposium on Hematoxicology in New Drug Development
Publication Publié, 1997-06

Publication dans des actes

• Détails

Titre:	Docetaxel in combination with Amifostine (A) in metastatic breast cancer (MBC): A feasability and pharmacokinetic study of the EORTC-investigational drug branch for breast cancer (IDBBC)
Auteur:	Awada, Ahmad; Cornez, Nathalie; de Valeriola, Dominique; Gil, Thierry; Van Vreckem, Ann; Bartholomeus, Sylvie; Selleslags, Jean; Piccart-Gebhart, Martine; et al.
Informations sur la publication:	(Juin 1997: Lugano, Switzerland), Proceedings of the First International Symposium on Hematoxicology in New Drug Development
Statut de publication:	Publié, 1997-06
Sujet CREF:	Cancérologie
	Pharmacologie
Langue:	Anglais